TABLE 2.
Summary of the number and characteristics of soil carbapenem‐resistant bacteria isolated from samples described in Table 1
| Genus | Sample of origin | Number of isolates | Number of CP a isolates | Antibiotic resistant/intermediate (number of isolates) b |
|---|---|---|---|---|
| Achromobacter | S10 | 1 | 0 | MP (1), CF (1) |
| Bradyrhizobium | S11 | 1 | 1 | MP (1), IM (1), CF (1), CI (1), GE (1), TE (1) |
| Cupriavidus | S2, 7, 8, 9 | 8 | 0 | MP (8), IM (2), CF (2), GE (4) |
| Enterococcus | S7, 11, 12 | 3 | 1 | MP (3), IM (2), CF (3), GE (1) |
| Planomicrobium | S7 | 1 | 0 | MP (1), IM (1), CF (1), GE (1), TE (1) |
| Pseudomonas | S2, 3, 4, 5, 11 | 15 | 3 | MP (15), IM (5), CF (14), GE (1), TE (1) |
| Stenotrophomonas | S1, 7, 11 | 11 | 11 | MP (11), IM (11), CF (3), GE (8), TE (8) |
| Total | 40 | 16 | MP (40), IM (22), CF (33), CI (1), GE (17), TE (11) |
a
CP = carbapenemase‐producing isolates as determined by the CarbaNP test and confirmed using the mCIM method.
b
The number of isolates that were resistant or intermediate to meropenem (MP), imipenem (IM), cefotaxime (CF), ciprofloxacin (CI), gentamicin (GE), and tetracycline (TE) is shown in parentheses. The detailed antibiotic susceptibility profile and carbapenemase production result for each isolate are provided in Table 3.